efficacy of semaglutide and tirzepatide in reducing liver fat versus Once Weekly Patients with Type 2 Diabetes Triple hormone receptor agonist retatrutide

The World Health Organization (WHO) has warned that the ongoing outbreak of the Bundibugyo strain of Ebola in the Democratic Republic of the Congo (DRC) has reached record levels, with the majority of new infections now originating from unknown chains of transmission, raising concerns over the virus's accelerating spread

Chouinard, V

Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: A systematic review and meta-analysis of randomized controlled trials

Key Endpoints Emerging for Diabetes Biomarkers and Prediction Models Islet autoantibodies against insulin/proinsulin, GAD65, IA-2, and ZnT8 serve as enrichment biomarkers for type 1 diabetes prevention studies Accelerated failure time models incorporating islet autoantibody permutations predict time-varying probability of T1D diagnosis Prediction accuracy improves with variables including baseline age, sex, blood glucose measurements, and hemoglobin A1c Metabolomics is emerging for precision diabetes medicine to discover biomarkers for diagnosis, prognosis, and management Machine learning models integrating genomic and proteomic data achieve 95% prediction accuracy for GLP-1 therapy response Cardiovascular Outcomes Bempedoic acid shows significant cardiovascular risk reduction in diabetes patients (HR 0.83

462 (96%) patients in the semaglutide 20 mg group and 471 (98%) in the semaglutide 10 mg group completed the trial

Brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) cost $800$1,400/month without insurance